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ABSTRACT:
Introduction: Diabetes mellitus is a type of metabolic disorder characterized by hyperglycemia resulting from defect 
in insulin secretion, insulin action or both. This study intended to compare High Density Lipoprotein Cholesterol 
(HDL) and Low Density Lipoprotein Cholesterol (LDL) profile between type II diabetic and non-diabetic subjects and 
also find the correlation between HDL and LDL cholesterol in type II diabetic. Methods: The study was conducted on 
100 total subjects out of which experimental group with 50 subjects of known Type II Diabetes mellitus and control 
group with 50 subjects. Results: The result of the present study suggests that fasting blood sugar and LDL cholesterol 
levels were increased but HDL cholesterol level was reduced in type II diabetic subjects when compared to controls. 
Conclusion: The estimation of HDL cholesterol and LDL cholesterol in type II diabetes mellitus is very useful as it 
may serve as a useful parameter to monitor the prognosis of the patient.
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INTRODUCTION:
Diabetes mellitus is a group of metabolic 
disorder characterized by hyperglycemia resulting 
from defect in insulin secretion, insulin action or 
both.1 Diabetes mellitus is characterized by either the 
absence of insulin that is Insulin Dependent Diabetes 
Mellitus (IDDM) type I or which is insensitive to 
the insulin that is Non-Insulin Dependent Diabetes 
Mellitus (NIDDM) or Type II. It is a complex 
disease where the carbohydrate and fat metabolism 
is impaired.2 Type II diabetes is associated with a 
marked increased risk of cardiovascular disease 
(CVD). Individuals with diabetes has an absolute 
risk of major coronary events similar to that of non-
diabetic individuals with established coronary heart 
disease (CHD).3 LDL Cholesterol is the main lipid 
marker in cardiovascular risk estimation and the 
principle therapeutic target in diabetic subjects.4 
High Density Lipoprotein (HDL) cholesterol is 
inversely correlated with cardiovascular events in 
all major epidemiological studies. Strategies have 
demonstrated that increased HDL cholesterol is 
associated with decreased cardiovascular risk in 
high risk individuals such as patients with type II 
diabetes.5 Abnormal lipid profile is more common 
in diabetics and get aggravated with poor glycemic 
control. Thus, the measurement of lipid profile is 
needed to investigate how their lipid metabolism 
especially HDL and LDL cholesterol is affected by 
diabetes. Also, the correlation of HDL cholesterol 
and LDL cholesterol in diabetics and non-diabetics 
was observed in this study.6 High level of LDL 
cholesterol and low HDL cholesterol may be due 
to obesity, increased calorie intake and a lack of 
muscular exercise in the patients of diabetes mellitus.2 
Hence this study was designed where in HDL and 
LDL cholesterol levels have been correlated for 
diabetic and non-diabetic healthy subjects.7
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METHODS:
 A Case-Control study with 50 controls as 
non-diabetic cases and 50 cases as Diabetic patients 
was undertaken to study the HDL and LDL profile.
The present study was carried out on total 100 
subjects, which were divided into two groups- 
experimental group which consisted of 50 subjects 
with known Type II Diabetes mellitus and control 
group which consisted of 50 healthy non- diabetic 
subjects with no present and past family history of 
diabetes mellitus. A total 50 type II diabetic subjects 
were recruited in the study, among which 35 were 
males and 15 were females in the age group of 40-
70 years. Non-insulin dependent diabetes mellitus 
patients were being treated by diet alone or diet 
combined with oral hypoglycemic agents.
RESULTS:
 The study was a case control study where 
fasting plasma glucose, serum HDL cholesterol, 
serum LDL cholesterol was estimated, compared 
and correlated in type II diabetic and non-diabetic 
subjects. 
 Table 1 and Table 2 show that the mean age 
studied in type-II diabetes mellitus patients was 
54.34 yrs (SD=8.48) and 53.40 yrs (SD=7.95) in 
control subjects showing a suggestive significance 
p=0.57. Whereas the percentage of gender study 
showed the control group with 54% male and 46% 
female when compared to case group male 68% and 
32% female showing a non significant difference, 
p=0.15. Hence, suggesting that the study comprised
of equal distribution of age group and gender.
 Table 3 shows that fasting plasma glucose 
and serum LDL cholesterol levels were elevated in 
case group with mean 164.56 mg (SD=51.17) and 
121.42 mg (SD=27.89) respectively when compared 
to the control group mean of 95.48 mg (SD=10.09) 
and 103.64 mg (SD=30.67) respectively. A strong 
significance (p<0.001 and p=0.003) was found 
between case and control group’s mean fasting 
plasma glucose and serum LDL cholesterol levels 
respectively. Whereas HDL cholesterol levels had 
fall in case group mean (39.22±7.96) when compared 
to the control group (44.06±10.57)   showing a p 
value of 0.011. 
 Table 4 shows a comparison of HDL 
cholesterol in case and control. A strong significance 
is observed when compared with HDL cholesterol 
level <40mg/dl (p<0.001) and HDL cholesterol 
level is 40-60mg/dl (p<0.001). A significant lower 
incidence of HDL cholesterol levels is seen in case 
group than in controls (76% verses 32% respectively 
where HDL <40.0 mg/dl and 22% verses 60% 
respectively where HDL is in between 40-60 mg/
dl, p<0.001). Whereas there was no significant in 
control and case group where HDL cholesterol 
levels where > 60mg/dl (p=0.36).
Table 1: Age distribution
Table 2: Gender distribution
Table 3: Comparison of blood parameters
Table 4: Comparison of HDL
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 Table 5 shows a significant negative 
correlation between HDL and LDL cholesterol (r 
= -0.221) where in the LDL cholesterol levels are 
elevated whereas HDL cholesterol is reduced in 
case groups compared to control group which is 
significant. 
Table 5: Comparison of LDL
DISCUSSION:
 The result obtained from present study has 
confirmed that the previous observations of an 
increased LDL and decreased HDL cholesterol levels 
in diabetic patients.8 Type II diabetes mellitus is 
chronic degenerative disease of epidemic proportion 
and is one of the major challenges to public health.9
The mean age studied in type II diabetes mellitus 
patients control subjects was 54.34 yes (SD= 8.48) 
53.40 yrs (SD=7.95) respectively. There appears to 
be no sex predilection for type II diabetes mellitus 
according to this study. This is similar to other 
studies that reported no significant differences in 
the prevalence of type II diabetes mellitus between 
males and females.10 The fasting blood glucose 
levels are elevated significantly (p<0.001) in 
NIDDM patients, when compared to the controls 
which is   consistent with earlier reports by other 
researchers.11-13 The HDL cholesterol was low in type 
II patients when compared to control. The decrease 
was found to be moderately significant (p= 0.01) in 
type II patients. Similar studies have been reported 
by Harno K.14 The reduction of HDL cholesterol in 
type II diabetic patients may be due to the increased 
activity of hepatic lipase, which plays an important 
role in HDL metabolism.14 However controversial 
studies also have been reported where no significant 
change in HDL cholesterol levels in diabetic 
patients reported.15 HDL cholesterol concentration 
are strongly and independently related to coronary 
artery disease, but the relationship is inverse; a low 
HDL cholesterol being an important predictor of 
coronary heart disease and whereas high levels of 
HDL cholesterol is protecting against coronary heart 
disease. A possible explanation for these finding 
is the role played by HDL cholesterol in reverse 
cholesterol transport as an acceptor of cellular 
free cholesterol.16 The LDL cholesterol is elevated 
significantly (p<0.003) in type I diabetic patients 
when compared to control. However, there was a 
small correlation between LDL cholesterol in type II 
diabetic patients. The above findings are consistent 
with the observations by other researchers.17
 Metabolic reasons for lower HDL levels have 
not been fully documented. Decreased synthesis of 
HDL has been found in one small study.18 Schmitt 
JK suggested that LDL uptake by fibroblasts may 
be impaired in type II diabetics. This may have 
led to increase in LDL cholesterol and decrease in 
HDL cholesterol in type II diabetics.II This is much 
similar to our study showing a negative correlation 
between LDL and HDL cholesterol (r = -0.221) in 
diabetics. 
CONCLUSION:
 The estimation of HDL cholesterol and LDL 
cholesterol in type II diabetes mellitus is very useful 
as it may serve as a useful parameter to monitor the 
prognosis of the patient. The detection of risk factor 
in the early stage of the disease will help the patients 
to improve and reduce the morbidity rate. The result 
of the present study suggests that fasting blood 
sugar and LDL cholesterol levels were found to be 
increased in type II diabetic subjects when compared 
to controls. The HDL cholesterol level was reduced 
statistically in diabetics when compared to controls. 
A significant negative correlation was observed 
between HDL and LDL cholesterol in diabetic 
subject.
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